87
Participants
Start Date
April 28, 2014
Primary Completion Date
May 10, 2017
Study Completion Date
May 10, 2017
IMVAMUNE®
0.5 ml Modified Vaccinia Ankara Strain - Bavarian Nordic (MVA-BN®) smallpox vaccine containing at least 1 x 10E8 TCID50 per ml
University of Pennsylvania Clinical Trials Unit, Philadelphia
Dupont Circle Physicians Group, Washington D.C.
Infectious Disease Associats of NW Florida Center for Prevention and Treatment of Infections Infectious Diseases Associates of NW FL, Pensacola
Rowan Tree Medical, Wilton Manors
University of Alabama at Birmingham, Birmingham
University of Iowa Departments of Internal Medicine and Microbiology University of Iowa, Iowa City
University of Illinois - Chicago, Chicago
Washington University School of Medicine, St Louis
Health for Life Clinic Little Rock, Little Rock
Quest Clinical Research, San Francisco
Clinical Research Puerto Rico, Inc., San Juan
Fundacion de Investigacion, San Juan
Lead Sponsor
Bavarian Nordic
INDUSTRY